¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2031³â)
Yersinia Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»óǰÄÚµå
:
1568983
¸®¼Ä¡»ç
:
Persistence Market Research
¹ßÇàÀÏ
:
2024³â 10¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 210 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ¿¹¸£½Ã´Ï¾Æ Áø´Ü ¼¼°è ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çϰí, ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çß½À´Ï´Ù. ÀÌ »ó¼¼ÇÑ º¸°í¼´Â ½ÃÀå ±¸Á¶¿Í ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀå °¡´É¼º¿¡ ´ëÇØ ¹àÇû½À´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå ±Ô¸ð(2024³â) : 3¾ï 470¸¸ ´Þ·¯
¿¹Ãø ½ÃÀå ±Ô¸ð(2031³â) : 4¾ï 6,700¸¸ ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2031³â±îÁö) : 6.3%
¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå - º¸°í ¹üÀ§:
¿¹¸£½Ã´Ï¾Æ Áø´Ü¿¡´Â ¿¹¸£½Ã´Ï¾ÆÁõ°ú Æä½ºÆ®¿Í °°Àº Áúº´À» ÀÏÀ¸Å°´Â ¿¹¸£½Ã´Ï¾Æ ¿£Å×·ÎÄÚ¸®Æ¼Ä« ¹× ¿¹¸£½Ã´Ï¾Æ Æä½ºÆ¼½º¿Í °°Àº ¿¹¸£½Ã´Ï¾Æ °¨¿°À» °ËÃâÇϱâ À§ÇÑ ´Ù¾çÇÑ Áø´Ü ¹æ¹ýÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº ¿¹¸£½Ã´Ï¾Æ °¨¿°ÀÇ ¹ß»ý·ü Áõ°¡, ºÐÀÚÁø´Ü ±â¼úÀÇ Áøº¸, Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ½ÃÇè(POCT) ¼Ö·ç¼Ç ¼ö¿ä Áõ°¡¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
¸î °¡Áö ¿äÀÎÀÌ ¼¼°è ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸£½Ã´Ï¾Æ °ü·Ã ÁúȯÀÇ ÀÌȯÀ² »ó½Â, ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) ¹× Â÷¼¼´ë ½ÃÄö½Ì(NGS) µî ½Å¼Ó Áø´Ü ±â¼úÀÇ Ã¤¿ëÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ½ÃÇè ÀåÄ¡´Â ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼ ¿¹¸£½Ã´Ï¾Æ º´¿øÃ¼ÀÇ ½Å¼ÓÇÑ ÇöÀå °ËÃâÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â ´É·ÂÀ¸·Î ÁöÁö¸¦ ¸ðÀ¸°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:
¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀåÀº ¿©·¯ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¿¹¸£½Ã´Ï¾Æ ±ÕÁÖÀÇ ´Ù¾ç¼º°ú ´Ù¾çÇÑ È¯ÀÚ Áý´Ü¿¡¼ ¿¹¸£½Ã´Ï¾Æ °¨¿°ÀÇ Áø´ÜÀÇ º¹À⼺Àº Á¤È®ÇÑ Áø´Ü ½ÃÇè °³¹ßÀ» ¾î·Æ°Ô ¸¸µì´Ï´Ù. ¶ÇÇÑ Á¦ÇÑµÈ ÀÚ¿ø ȯ°æ¿¡¼´Â ºñ¿ë Á¦¾à°ú °í±Þ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¾×¼¼½º°¡ Á¦ÇÑµÇ¾î ½ÃÀå ħÅõ¸¦ ¹æÇØÇÕ´Ï´Ù.
½ÃÀå ±âȸ:
¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀåÀº ƯÈ÷ POCT Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á¤¹ÐÀÇ·áÀÇ ÃâÇöÀ¸·Î Å« ±âȸ¸¦ Á¦½ÃÇÕ´Ï´Ù. ºÐÀÚÁø´ÜÀº ´õ ³ôÀº °¨µµ, ƯÀ̼º ¹× ´õ ºü¸¥ °á°ú¸¦ ¾òÀ» ¼ö Àֱ⠶§¹®¿¡ Á¡Á¡ äÅõǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á Á¦°ø¾÷ü¿ÍÀÇ Çù·Â°ú ¿¹¸£½Ã´Ï¾Æ °¨¿°À» À§ÇÑ ¸ÂÃãÇü Áø´Ü¹ýÀÇ °³¹ßÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
¿¹¸£½Ã´Ï¾Æ Áø´ÜÀÇ µµÀÔÀÌ °¡Àå ÁøÇàµÇ°í ÀÖ´Â Áö¿ªÀº?
Áø´Ü ±â¼úÀÇ ¹ßÀüÀº °æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?
¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¾îµò°¡, ±×¸®°í ½ÃÀå Æ÷Áö¼ÇÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ½Ç½ÃÇϰí Àִ°¡?
¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå¿¡¼ÀÇ »õ·Î¿î µ¿Çâ°ú Àå·¡¼ºÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¾ïÁ¦¿äÀÎ
±âȸ
ÁÖ¿ä µ¿Çâ
°Å½Ã°æÁ¦ ¿äÀÎ
¼¼°èÀÇ ¼½Åͺ° Àü¸Á
¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
¼¼°èÀÇ ÀÇ·áºñ ÁöÃâ Àü¸Á
COVID-19ÀÇ ¿µÇ⠺м®
¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
Á¦3Àå ºÎ°¡°¡Ä¡ ÅëÂû
Á¦Ç° ä¿ë ºÐ¼®
Áúº´ ¿ªÇÐ
±â¼úÆò°¡
±ÔÁ¦ »óȲ
°ø±Þ¸Á ºÐ¼®
ÁÖ¿ä °Å·¡¿Í ÇÕº´
PESTLE ºÐ¼®
Porter's Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)
½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í Àü³â´ëºñ ¼ºÀå·ü
Àý´ë ±Ý¾× ±âȸ
½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á:Á¦Ç°
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, Á¦Ç°º°, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°
¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: Áø´Ü ½ÃÇè
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, Áø´Ü½ÃÇ躰, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, Áø´Ü ½ÃÇ躰, 2024-2033³â
´ëº¯ ¹è¾ç
È»ó½ÃÇè
Ç÷ûÇÐÀû ½ÃÇè
´ëÀå³»½Ã°æ½ÃÇè
±âŸ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áø´Ü ½ÃÇè
¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ±â¼ú
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, ±â¼úº°, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2033³â
¸é¿ª ÃøÁ¤
DNA ÇÁ·Îºê
ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR)
ÇÃ·Î¿ì »çÀÌÅä¸ÞÆ®¸®
Å©·Î¸¶Åä±×·¡ÇÇ
±âŸ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ±â¼ú
¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ÃÖÁ¾ »ç¿ëÀÚ
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, ÃÖÁ¾ »ç¿ëÀÚº°, 2019-2023³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
º´¿ø
°øÁßÀ§»ý¿¬±¸¼Ò
»ó¾÷¿¬±¸¼Ò
±âŸ
½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚ
Á¦5Àå ¼¼°èÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á : Áö¿ª
2019-2023³â¿¡ ÀÖ¾î¼ÀÇ Áö¿ªº° ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ °ú°Å ºÐ¼®
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°, 2024-2033³â
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀåÀÇ ¸Å·Â ºÐ¼® :Áö¿ª
Á¦6Àå ºÏ¹ÌÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)
Á¦7Àå À¯·´ÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)
Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)
Á¦9Àå ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾ÆÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)
Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)
Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿¹¸£½Ã´Ï¾Æ Áø´Ü ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)
Á¦12Àå °æÀï ±¸µµ
½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
½ÃÀå ±¸Á¶
½ÃÀ庰 °æÀï °µµ ¸ÅÇÎ
°æÀï ´ë½Ãº¸µå
±â¾÷ ÇÁ·ÎÆÄÀÏ(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
TestLine Clinical Diagnostics sro
CERTEST BIOTEC
T2 Biosystems
Demeditec Diagnostics GmbH
Launch Diagnostics Limited
ELITech Group
Advanced Molecular Diagnostics
SeraCare(LGC Clinical Diagnostics)
Hygiena LLC
Diagnostiki Athinon
QED Bioscience Inc.
BioFire Defense
VIROTECH Diagnostics GmbH
Thermo Fisher Scientific Inc.
Seegene Inc.
Diasorin SpA
Á¦13Àå ºÎ·Ï
Á¶»ç ¹æ¹ý
Á¶»çÀÇ ÀüÁ¦
µÎÀÚ¾î ¹× ¾à¾î
JHS
¿µ¹® ¸ñÂ÷
Persistence Market Research has recently released a comprehensive report on the global Yersinia Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.
Key Insights:
Yersinia Diagnostics Market Size (2024E): US$304.7 Million
Projected Market Value (2031F): US$467.0 Million
Global Market Growth Rate (CAGR 2024 to 2031): 6.3%
Yersinia Diagnostics Market - Report Scope:
Yersinia diagnostics encompasses various diagnostic methods for detecting Yersinia infections, such as Yersinia enterocolitica and Yersinia pestis, which cause diseases like yersiniosis and plague. The market is driven by the growing incidence of Yersinia infections, advancements in molecular diagnostic technologies, and the increasing demand for point-of-care testing (POCT) solutions.
Market Growth Drivers:
Several factors are driving the growth of the global Yersinia Diagnostics Market. The rising incidence of Yersinia-related diseases and the introduction of rapid diagnostic techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) are contributing to market expansion. Additionally, point-of-care testing devices are gaining traction for their ability to facilitate quick on-site detection of Yersinia pathogens in various healthcare settings.
Market Restraints:
Despite the growth prospects, the Yersinia Diagnostics Market faces several challenges. The variability of Yersinia strains and the complexity of diagnosing Yersinia infections across diverse patient groups create difficulties in developing accurate diagnostic tests. Cost constraints and limited access to advanced diagnostic tools in resource-limited settings also hinder market penetration.
Market Opportunities:
The Yersinia Diagnostics Market presents significant opportunities, especially with the rising demand for POCT devices and the emergence of precision medicine. Molecular diagnostics are increasingly being adopted for their higher sensitivity, specificity, and faster results. Additionally, collaborations with healthcare providers and the development of customized diagnostics for Yersinia infections are expected to drive market growth.
Key Questions Answered in the Report:
What are the primary factors driving the global Yersinia Diagnostics Market?
Which regions are witnessing the highest adoption of Yersinia diagnostics?
How are advancements in diagnostic technologies impacting the competitive landscape?
Who are the leading players in the Yersinia Diagnostics Market, and what strategies are they implementing to maintain their market positions?
What are the emerging trends and future prospects in the global Yersinia Diagnostics Market?
Competitive Intelligence and Business Strategy:
Leading players in the Yersinia Diagnostics Market, including TestLine Clinical Diagnostics, T2 Biosystems, and Demeditec Diagnostics, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic technologies such as PCR-based assays and multiplex tests to enhance the accuracy and speed of Yersinia diagnostics. Collaborations with public health agencies and research institutions are crucial for market penetration and sustained growth.
Key Companies Profiled:
TestLine Clinical Diagnostics s.r.o
CERTEST BIOTEC
T2 Biosystems
Demeditec Diagnostics GmbH
Launch Diagnostics Limited
ELITech Group
Advanced Molecular Diagnostics
SeraCare (LGC Clinical Diagnostics)
Hygiena LLC
Diagnostiki Athinon
QED Bioscience Inc.
BioFire Defense
VIROTECH Diagnostics GmbH
Thermo Fisher Scientific Inc.
Seegene Inc.
Diasorin S.p.A.
Yersinia Diagnostics Market - Segmentation
Product
Instruments
Kits and Reagents
Diagnostic Test
Stool Culture
Imaging Tests
Serological Tests
Colonoscopy
Others
Technology
Immunoassay
DNA Probes
Polymerase Chain Reaction (PCR)
Flow Cytometry
Chromatography
Others
End Use
Hospitals
Public Health Laboratories
Commercial Laboratories
Others
Region
North America
Latin America
Europe
Middle East and Africa (MEA)
East Asia
South Asia
Oceania
Table of Contents
1. Executive Summary
1.1. Global Yersinia Diagnostics Market Snapshot, 2024-2033
1.2. Market Opportunity Assessment, 2024-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Disease Epidemiology
3.3. Technology Assessment
3.4. Regulatory Landscape
3.5. Supply Chain Analysis
3.6. Key Deals and Mergers
3.7. PESTLE Analysis
3.8. Porter's Five Force Analysis
4. Global Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
4.1. Key Highlights
4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2033
4.3. Global Yersinia Diagnostics Market Outlook: Product
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2023
4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
4.3.3.1. Instruments
4.3.3.2. Kits and Reagents
4.4. Market Attractiveness Analysis: Product
4.5. Global Yersinia Diagnostics Market Outlook: Diagnostic Test
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By Diagnostic Test, 2019-2023
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
4.5.3.1. Stool Culture
4.5.3.2. Imaging Tests
4.5.3.3. Serological Tests
4.5.3.4. Colonoscopy
4.5.3.5. Others
4.6. Market Attractiveness Analysis: Diagnostic Test
4.7. Global Yersinia Diagnostics Market Outlook: Technology
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2023
4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
4.7.3.1. Immunoassay
4.7.3.2. DNA Probes
4.7.3.3. Polymerase Chain Reaction (PCR)
4.7.3.4. Flow Cytometry
4.7.3.5. Chromatography
4.7.3.6. Others
4.8. Market Attractiveness Analysis: Technology
4.9. Global Yersinia Diagnostics Market Outlook: End User
4.9.1. Introduction / Key Findings
4.9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
4.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
4.9.3.1. Hospitals
4.9.3.2. Public Health Laboratories
4.9.3.3. Commercial Laboratories
4.9.3.4. Others
4.10. Market Attractiveness Analysis: End User
5. Global Yersinia Diagnostics Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2033
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
6.2.1. By Country
6.2.2. By Product
6.2.3. By Diagnostic Test
6.2.4. By Technology
6.2.5. By End User
6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
6.4.1. Instruments
6.4.2. Kits and Reagents
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
6.5.1. Stool Culture
6.5.2. Imaging Tests
6.5.3. Serological Tests
6.5.4. Colonoscopy
6.5.5. Others
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
6.6.1. Immunoassay
6.6.2. DNA Probes
6.6.3. Polymerase Chain Reaction (PCR)
6.6.4. Flow Cytometry
6.6.5. Chromatography
6.6.6. Others
6.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
6.7.1. Hospitals
6.7.2. Public Health Laboratories
6.7.3. Commercial Laboratories
6.7.4. Others
6.8. Market Attractiveness Analysis
7. Europe Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
7.2.1. By Country
7.2.2. By Product
7.2.3. By Diagnostic Test
7.2.4. By Technology
7.2.5. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
7.4.1. Instruments
7.4.2. Kits and Reagents
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
7.5.1. Stool Culture
7.5.2. Imaging Tests
7.5.3. Serological Tests
7.5.4. Colonoscopy
7.5.5. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
7.6.1. Immunoassay
7.6.2. DNA Probes
7.6.3. Polymerase Chain Reaction (PCR)
7.6.4. Flow Cytometry
7.6.5. Chromatography
7.6.6. Others
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
7.7.1. Hospitals
7.7.2. Public Health Laboratories
7.7.3. Commercial Laboratories
7.7.4. Others
7.8. Market Attractiveness Analysis
8. East Asia Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
8.2.1. By Country
8.2.2. By Product
8.2.3. By Diagnostic Test
8.2.4. By Technology
8.2.5. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
8.4.1. Instruments
8.4.2. Kits and Reagents
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
8.5.1. Stool Culture
8.5.2. Imaging Tests
8.5.3. Serological Tests
8.5.4. Colonoscopy
8.5.5. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
8.6.1. Immunoassay
8.6.2. DNA Probes
8.6.3. Polymerase Chain Reaction (PCR)
8.6.4. Flow Cytometry
8.6.5. Chromatography
8.6.6. Others
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
8.7.1. Hospitals
8.7.2. Public Health Laboratories
8.7.3. Commercial Laboratories
8.7.4. Others
8.8. Market Attractiveness Analysis
9. South Asia & Oceania Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
9.2.1. By Country
9.2.2. By Product
9.2.3. By Diagnostic Test
9.2.4. By Technology
9.2.5. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
9.4.1. Instruments
9.4.2. Kits and Reagents
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
9.5.1. Stool Culture
9.5.2. Imaging Tests
9.5.3. Serological Tests
9.5.4. Colonoscopy
9.5.5. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
9.6.1. Immunoassay
9.6.2. DNA Probes
9.6.3. Polymerase Chain Reaction (PCR)
9.6.4. Flow Cytometry
9.6.5. Chromatography
9.6.6. Others
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
9.7.1. Hospitals
9.7.2. Public Health Laboratories
9.7.3. Commercial Laboratories
9.7.4. Others
9.8. Market Attractiveness Analysis
10. Latin America Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
10.2.1. By Country
10.2.2. By Product
10.2.3. By Diagnostic Test
10.2.4. By Technology
10.2.5. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
10.4.1. Instruments
10.4.2. Kits and Reagents
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
10.5.1. Stool Culture
10.5.2. Imaging Tests
10.5.3. Serological Tests
10.5.4. Colonoscopy
10.5.5. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
10.6.1. Immunoassay
10.6.2. DNA Probes
10.6.3. Polymerase Chain Reaction (PCR)
10.6.4. Flow Cytometry
10.6.5. Chromatography
10.6.6. Others
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
10.7.1. Hospitals
10.7.2. Public Health Laboratories
10.7.3. Commercial Laboratories
10.7.4. Others
10.8. Market Attractiveness Analysis
11. Middle East & Africa Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
11.2.1. By Country
11.2.2. By Product
11.2.3. By Diagnostic Test
11.2.4. By Technology
11.2.5. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
11.4.1. Instruments
11.4.2. Kits and Reagents
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
11.5.1. Stool Culture
11.5.2. Imaging Tests
11.5.3. Serological Tests
11.5.4. Colonoscopy
11.5.5. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
11.6.1. Immunoassay
11.6.2. DNA Probes
11.6.3. Polymerase Chain Reaction (PCR)
11.6.4. Flow Cytometry
11.6.5. Chromatography
11.6.6. Others
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
11.7.1. Hospitals
11.7.2. Public Health Laboratories
11.7.3. Commercial Laboratories
11.7.4. Others
11.8. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2024
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. TestLine Clinical Diagnostics s.r.o
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. CERTEST BIOTEC
12.3.2.1. Overview
12.3.2.2. Segments and Products
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. T2 Biosystems
12.3.3.1. Overview
12.3.3.2. Segments and Products
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Demeditec Diagnostics GmbH
12.3.4.1. Overview
12.3.4.2. Segments and Products
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Launch Diagnostics Limited
12.3.5.1. Overview
12.3.5.2. Segments and Products
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. ELITech Group
12.3.6.1. Overview
12.3.6.2. Segments and Products
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. Advanced Molecular Diagnostics
12.3.7.1. Overview
12.3.7.2. Segments and Products
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. SeraCare (LGC Clinical Diagnostics)
12.3.8.1. Overview
12.3.8.2. Segments and Products
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. Hygiena LLC
12.3.9.1. Overview
12.3.9.2. Segments and Products
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
12.3.10. Diagnostiki Athinon
12.3.10.1. Overview
12.3.10.2. Segments and Products
12.3.10.3. Key Financials
12.3.10.4. Market Developments
12.3.10.5. Market Strategy
12.3.11. QED Bioscience Inc.
12.3.11.1. Overview
12.3.11.2. Segments and Products
12.3.11.3. Key Financials
12.3.11.4. Market Developments
12.3.11.5. Market Strategy
12.3.12. BioFire Defense
12.3.12.1. Overview
12.3.12.2. Segments and Products
12.3.12.3. Key Financials
12.3.12.4. Market Developments
12.3.12.5. Market Strategy
12.3.13. VIROTECH Diagnostics GmbH
12.3.13.1. Overview
12.3.13.2. Segments and Products
12.3.13.3. Key Financials
12.3.13.4. Market Developments
12.3.13.5. Market Strategy
12.3.14. Thermo Fisher Scientific Inc.
12.3.14.1. Overview
12.3.14.2. Segments and Products
12.3.14.3. Key Financials
12.3.14.4. Market Developments
12.3.14.5. Market Strategy
12.3.15. Seegene Inc.
12.3.15.1. Overview
12.3.15.2. Segments and Products
12.3.15.3. Key Financials
12.3.15.4. Market Developments
12.3.15.5. Market Strategy
12.3.16. Diasorin S.p.A.
12.3.16.1. Overview
12.3.16.2. Segments and Products
12.3.16.3. Key Financials
12.3.16.4. Market Developments
12.3.16.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
°ü·ÃÀÚ·á